G Vetter

683 total citations
11 papers, 533 citations indexed

About

G Vetter is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, G Vetter has authored 11 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in G Vetter's work include Inflammatory mediators and NSAID effects (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). G Vetter is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). G Vetter collaborates with scholars based in Germany, Switzerland and Italy. G Vetter's co-authors include Pieter J. Beks, Gerhard Bach, Endre A. Balazs, Lydia‐Marie Joubert, D Hartmann, Matthias Beyer, Christiane Muth, M. Braun, H. W. Asbach and Jay Gross and has published in prestigious journals such as The American Journal of Medicine, Clinical Therapeutics and International Journal of Clinical Pharmacology and Therapeutics.

In The Last Decade

G Vetter

10 papers receiving 471 citations

Peers

G Vetter
Patrick Donnelly United Kingdom
Di Zhao China
Serpil Kalkan Türkiye
R. Grant United Kingdom
Christine E. McLennan United States
Patrick Donnelly United Kingdom
G Vetter
Citations per year, relative to G Vetter G Vetter (= 1×) peers Patrick Donnelly

Countries citing papers authored by G Vetter

Since Specialization
Citations

This map shows the geographic impact of G Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Vetter more than expected).

Fields of papers citing papers by G Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Vetter. The network helps show where G Vetter may publish in the future.

Co-authorship network of co-authors of G Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of G Vetter. A scholar is included among the top collaborators of G Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Vetter. G Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vetter, G, et al.. (2018). What Drives Decision Makers to Follow or Ignore Forecasting Tools - A Game Based Analysis. Proceedings of the ... Annual Hawaii International Conference on System Sciences. 1 indexed citations
2.
Braun, M., Jay Gross, G Vetter, et al.. (2014). Recommendations for Treating Adult and Geriatric Patients on Multimedication. International Journal of Clinical Pharmacology and Therapeutics. 52(S1). 1–64. 29 indexed citations
4.
Vetter, G, et al.. (1998). Viscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clinical Therapeutics. 20(3). 410–423. 241 indexed citations
5.
Dietrich, M., et al.. (1992). Evaluation of the once-daily activity of REC 15/2375 in the treatment of mild to moderate hypertension. Current Therapeutic Research. 52(1). 196–201. 3 indexed citations
6.
Vetter, G, et al.. (1989). [Shortening diclofenac therapy by B vitamins. Results of a randomized double-blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes].. PubMed. 47(5). 351–62. 24 indexed citations
7.
Vetter, G. (1987). Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. The American Journal of Medicine. 83(5). 78–80. 29 indexed citations
8.
Hartmann, D, et al.. (1987). Study on the possible interaction between tenoxicam and furosemide.. PubMed. 37(9). 1072–6. 11 indexed citations
9.
Vetter, G, et al.. (1982). Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.. PubMed. 20(5). 240–5. 23 indexed citations
10.
Vetter, G. (1975). Double-blind cross-over study of clopirac and naproxen in rheumatoid arthritis.. PubMed. 30 Spec no. 107–11. 2 indexed citations
11.
Vetter, G. (1973). [Clinical testing of a new potassium-saving diuretic for the treatment of hypertension].. PubMed. 115(49). 2249–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026